Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Public ClinicalTrials.gov record NCT00250679. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Double-Blind, Double-Dummy, Randomized, Active-Controlled, Parallel Group Long-Term Safety Study of 15 μg and 25 μg Arformoterol Tartrate Inhalation Solution BID in Subjects With Chronic Obstructive Pulmonary Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the long-term safety and monitor the long-term efficacy of arformoterol over a period of 6 months in subjects with chronic obstructive pulmonary disease (COPD).
Study identification
- NCT ID
- NCT00250679
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 443 participants
Conditions and interventions
Interventions
- Arformoterol tartrate inhalation solution Drug
- Arformoterol 25 ųg BID Drug
- Formoterol 12 ųg BID Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 35 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2005 (Type not available)
- Primary completion
- Oct 2007 (Actual)
- Completion
- Oct 2007 (Actual)
- Last update posted
- Jun 4, 2012
2005 – 2007
United States locations
- U.S. sites
- 60
- U.S. states
- 26
- U.S. cities
- 59
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Jasper | Alabama | — | — |
| Not listed | Mobile | Alabama | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Carmichael | California | — | — |
| Not listed | Fullerton | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Paramount | California | — | — |
| Not listed | Rancho Mirage | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Walnut Creek | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Hartford | Connecticut | — | — |
| Not listed | Bay Pines | Florida | 33744 | — |
| Not listed | Brandon | Florida | — | — |
| Not listed | Gainesville | Florida | 32605 | — |
| Not listed | Panama City | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Atlanta | Georgia | 30309 | — |
| Not listed | Marietta | Georgia | — | — |
| Not listed | Normal | Illinois | — | — |
| Not listed | Evansville | Indiana | — | — |
| Not listed | Topeka | Kansas | — | — |
| Not listed | East Slidell | Louisiana | — | — |
| Not listed | Lafayette | Louisiana | — | — |
| Not listed | Metairie | Louisiana | — | — |
| Not listed | Sunset | Louisiana | — | — |
| Not listed | Baltimore | Maryland | — | — |
| Not listed | Chester | Maryland | — | — |
| Not listed | Wheaton | Maryland | — | — |
| Not listed | Ann Arbor | Michigan | — | — |
| Not listed | Saint Charles | Missouri | — | — |
| Not listed | St Louis | Missouri | 63117 | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Chapel Hill | North Carolina | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Statesville | North Carolina | 28625 | — |
| Not listed | Wilmington | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Lake Oswego | Oregon | — | — |
| Not listed | Medford | Oregon | 97504 | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | Swarthmore | Pennsylvania | — | — |
| Not listed | East Providence | Rhode Island | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Columbia | South Carolina | — | — |
| Not listed | Simpsonville | South Carolina | — | — |
| Not listed | Spartanburg | South Carolina | — | — |
| Not listed | Union | South Carolina | 29379 | — |
| Not listed | Knoxville | Tennessee | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Katy | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Danville | Virginia | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Spokane | Washington | — | — |
| Not listed | Tacoma | Washington | — | — |
| Not listed | Morgantown | West Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00250679, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2012 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00250679 live on ClinicalTrials.gov.